build1 publisher
ARPA-H puts up to $9.5 million behind testing whether an agent can adjust heart-failure care
The award to Tempus funds product development and a prospective multicenter study of an autonomous version of its Olivia app, and ARPA-H wants an FDA authorization package filed within 24 months.
Publishers:runtimewire.com
Reality
- Evidence48
- Adoption8
- Hype gap+12
- Incentives68
- Confidence58